Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ECC-5004 by AstraZeneca for Type 2 Diabetes: Likelihood of Approval
ECC-5004 is under clinical development by AstraZeneca and currently in Phase I for Type 2 Diabetes. According to GlobalData, Phase...
Data Insights
ECC-5004 by AstraZeneca for Obesity: Likelihood of Approval
ECC-5004 is under clinical development by AstraZeneca and currently in Phase I for Obesity. According to GlobalData, Phase I drugs...